WellPoint
Executive Summary
Four drugs added to Blue Cross of California formulary, including Schering-Plough's Claritin, Knoll's Dilaudid, SmithKline Beecham's Paxil and Janssen's Propulsid. Blue Cross' newsletter to pharmacies notes that Paxil "should be reserved for patients who cannot tolerate the side effects or who do not respond to the tricyclic antidepressants." Propulsid "should be reserved for patients who have failed or cannot tolerate metoclopramide." The pharmacy benefits company is adding a pharmacy incentive, paying pharmacies "an annual bonus of $0.20 on each generic prescription dispensed if [their] generic substitution rate surpasses 79.99% of the available multi-source medications." An additional annual bonus of $0.30 will be paid for each drug dispensed that is listed on the Blue Cross of California formulary if the pharmacy's formulary dispensing rate is greater than 84.99%, the company says